Literature DB >> 11756004

CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis.

I Djilali-Saiah1, P Ouellette, S Caillat-Zucman, D Debray, J I Kohn, F Alvarez.   

Abstract

Susceptibility to autoimmune hepatitis is associated with particular human leucocyte antigen class II alleles. However, non-HLA genetic factors are likely to be required for development of the disease. Among the candidate genes, the cytotoxic T-lymphocyte antigen 4 (CTLA-4) and CD28 genes, located on chromosome 2q33 in humans, encode a cell surface molecule playing a dominant role in the regulation of T-cell activation. The CTLA-4 and CD28 polymorphisms were investigated in children from 32 families with autoimmune hepatitis (AIH). The transmission/disequilibrium test revealed increased transmission of the (AT)8 (dinucleotide repeat) and A (exon 1) alleles of CTLA-4 gene from heterozygous parents to affected offspring (87.5% and 83.5%) with type 1 AIH, compared with unaffected offspring (50.0% for both, p = 0.009 and 0.02, respectively). In contrast, no deviation in transmission for CTLA-4 polymorphisms was found between type 2 AIH patients and unaffected offspring. No evidence for association was found between CD28 gene polymorphism or D2S72 genetic marker and both types of AIH. This study identified the CTLA-4 gene polymorphism as a non-HLA determinant that predisposes to AIH type 1 in children. The genetic heterogeneity seen in the present study provides a new argument in favor of pathogenic differences between type 1 and type 2 AIH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11756004     DOI: 10.1016/s0198-8859(01)00344-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  16 in total

Review 1.  CTLA4 gene and autoimmune endocrinopathies: a new marker?

Authors:  F Pociot
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

Review 2.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

Review 3.  Autoimmune hepatitis in childhood: the role of genetic and immune factors.

Authors:  Priscila Menezes Ferri Liu; Débora Marques de Miranda; Eleonora Druve Tavares Fagundes; Alexandre Rodrigues Ferreira; Ana Cristina Simões e Silva
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

4.  CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients.

Authors:  Shaoqiong Duan; Guoyu Zhang; Qunying Han; Zhu Li; Zhengwen Liu; Jinghong Chen; Yi Lv; Na Li; Yawen Wang; Man Li; Sai Lou; Mingbo Yang; Qianqian Zhu; Fanfan Xing
Journal:  Mol Biol Rep       Date:  2010-12-15       Impact factor: 2.316

5.  CTLA-4 Gene Haplotypes and the Risk of Chronic Hepatitis C Infection; a Case Control Study.

Authors:  Samaneh Sepahi; Alireza Pasdar; Sina Gerayli; Sina Rostami; Aida Gholoobi; Zahra Meshkat
Journal:  Rep Biochem Mol Biol       Date:  2017-10

6.  Genetic susceptibility to autoimmune liver disease.

Authors:  Jochen Mattner
Journal:  World J Hepatol       Date:  2011-01-27

7.  Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population.

Authors:  Lie-Ying Fan; Xiao-Qing Tu; Qu-Bo Cheng; Ye Zhu; Ralph Feltens; Thomas Pfeiffer; Ren-Qian Zhong
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

Review 8.  Influence of genes, sex, age and environment on the onset of autoimmune hepatitis.

Authors:  Kathie Béland; Pascal Lapierre; Fernando Alvarez
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

Review 9.  Genetic factors affect the etiology, clinical characteristics and outcome of autoimmune hepatitis.

Authors:  Takeji Umemura; Masao Ota
Journal:  Clin J Gastroenterol       Date:  2015-12-10

10.  Xenobiotic exposure and autoimmune hepatitis.

Authors:  Kathleen M Gilbert
Journal:  Hepat Res Treat       Date:  2010-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.